ClinicalTrials.gg
CompletedNCT06103968Updated Feb 6, 2024

Influence of Gastric Tube Presence in Upholding the Correct Placement of LMA Blockbuster

An observational study in Anesthesia, sponsored by Aligarh Muslim University. Completed at 1 site in India. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by Aligarh Muslim University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
66
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Since its invention in 1981 by Dr. Archie Brain, the classical laryngeal mask airway (LMA ) has undergone many modifications. Today various LMAs are available that can also help in Ryle's tube insertion, intubation via LMA, deep extubation, adjunct in difficult airway and for spontaneous ventilation in short procedures.

One of the newer modifications is the Blockbuster LMA. It was invented by Prof. Ming Tian, the president of Chinese Difficult Airway Society and is being increasingly used for cases of difficult intubation. It has some unique features like its 95 degrees angulated airway that makes it easier to insert. It also has a gastric port and provides better sealing pressures at lower volumes.

However the one of the major concern with supraglottic airway is that despite correct placement it may dislodge, or its position may change intraoperatively especially in surgeries where patient position needs to be changed or patient is moved/transferred or head and neck surgeries.

In this study investigator wishes to evaluate weather gastric tube inserted through LMA helps in maintaining the LMA blockbuster placement by comparing fibreoptic bronchoscope (FOB) scores recorded immediately after LMA placement and at the end of the surgical procedure.

Read the detailed description

Following approval by the Board of studies, Department of anaesthesiology and ethical committee of this institution the study will be conducted in J N Medical College and hospital on 60 patients undergoing operative procedures under general anaesthesia. Patients will be included in the study after well informed written consent, including the information that they would be part of this ongoing institutional research.

STUDY DESIGN Prospective randomised controlled study

STUDY POPULATION The study will be conducted on 60 patients admitted to JNMCH, AMU Aligarh planned for operative procedure under general anaesthesia.

In this study investigator wishes to evaluate weather gastric tube inserted through LMA helps in maintaining the LMA blockbuster placement by comparing fibreoptic bronchoscope (FOB) scores recorded immediately after LMA placement and at the end of the surgical procedure.

02

Conditions studied

  • Anesthesia
03

In context

Lead sponsor

Aligarh Muslim University is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study will be conducted on 60 patients admitted to JNMCH, AMU Aligarh planned for operative procedure under general anaesthesia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ASA Grade I \& II patients
  • Age between 20-70 years
  • Weight between 40-70 kg
  • Patients of both sexes
  • All classes of MP Grades

Exclusion criteria

Exclusion Criteria:

  • Any pathology of the oral cavity that may obstruct the insertion of device
  • Mouth opening less than 2.5cm.
  • Potentially full stomach patients (trauma, morbid obesity, history of gastric regurgitation and heart burn, full term pregnancy)
  • risk of oesophageal reflux (hiatus hernia)
  • Bleeding disorder
  • Unable to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
66 participants (actual)
Patient registry
No

Interventions

  • DeviceLMA BLOCKBUSTER

    In this study we wish to evaluate weather gastric tube inserted through LMA helps in maintaining the LMA blockbuster placement by comparing fibreoptic bronchoscope (FOB) scores recorded immediately after LMA placement and at the end of the surgical procedure.

    Also known as: GASTRIC TUBE

06

What researchers measure

Primary outcomes

  1. POGO SCORE

    Grading the placement of LMA blockbuster through Fibreoptic Bronchoscope score of at the start and end of the surgery.

    Time frame: IMMEDIATELY AFTER LMA PLACEMENT AND AT THE END OF SURGERY JUST BEFORE REMOVAL OF LMA

Secondary outcomes

  1. GASTRIC TUBE INSERTION SUCCESS RATE

    Ease and success rate of gastric tube insertion; number of attempts taken if successfull

    Time frame: within 2 minutes of LMA Blockbuster placement

07

Study locations

1 site
  • Jawaharlal Nehru Medical College
    Aligarh, Uttar Pradesh 450331, India
08

References and documents

Publications

  • Brimacombe J, Vosoba Judd D, Tortely K, Barron E, Branagan H. Gastric tube-guided reinsertion of the ProSeal laryngeal mask airway. Anesth Analg. 2002 Jun;94(6):1670. doi: 10.1097/00000539-200206000-00062. No abstract available. PubMed 12032052 ↗

Individual participant data

Plan to share: No — Patient particulars, PAC sheets and informed consent.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06103968
Lead sponsor
Aligarh Muslim University
Responsible party
MUAZZAM HASAN (Assitant Professor, Aligarh Muslim University) — Principal investigator
First posted
Oct 27, 2023
Start date
Oct 30, 2023
Primary completion
Feb 3, 2024
Completion
Feb 5, 2024
Last update
Feb 6, 2024

Study contacts

MUAZZAM HASAN, MD
principal investigator · AMU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion